Bioventix

Bioventix FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Bioventix (BVXP.L) as of Nov 3, 2026 is 105.36 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 92.46 % — a change of 13.95% (higher).

FCF Conversion

105.36 %

YoY

13.95%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Bioventix is 2026 105.36 % . FCF Conversion Rate (FCF/EBITDA) of Bioventix was 2025 92.46 % . It decreases by 13.95% higher compared to the previous year.

The Bioventix FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
98.83 GBP
Jan 1, 2020
102.52 GBP
Jan 1, 2021
90.73 GBP
Jan 1, 2022
98.38 GBP
Jan 1, 2023
94.27 GBP
Jan 1, 2024
102.86 GBP
Jan 1, 2025
92.46 GBP
Jan 1, 2026
105.36 GBP
The Bioventix FCF Conversion history
YEARFCF ConversionYoY
105.36 %+13.95%
92.46 %-10.11%
102.86 %+9.11%
94.27 %-4.17%
98.38 %+8.43%
90.73 %-11.50%
102.52 %+3.74%
98.83 %-3.74%
102.67 %+28.42%
79.95 %-11.33%
90.17 %+13.52%
79.43 %-18.23%
97.13 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioventix Stock analysis

What does Bioventix do? Bioventix PLC is a well-known British provider of high-quality antibodies and innovative diagnostic products. The company has been operating in the industry for over 20 years. They specialize in producing antibodies that are specific to certain biomarkers and proteins with high precision and reproducibility. Bioventix PLC has a unique business model that allows them to maintain a high level of control over their supply chain and build strong relationships with their customers. They not only produce antibodies themselves but also sell licenses for their patents and technologies. The company also has its own research and development department that constantly works on improving existing products and developing new diagnostic products. Their diversification into different business areas, such as food and environmental analytics, has contributed to their growth and success so far. Overall, Bioventix PLC is an innovative and growing company that offers a wide range of high-quality and innovative products. Bioventix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioventix stock

FCF Conversion Rate (FCF/EBITDA) of Bioventix is 105.36 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Bioventix changed from 92.46 % to 105.36 %, representing a 13.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Bioventix since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Bioventix with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bioventix

All Key Metrics — Bioventix